Another strategy for combating antibiotic resistance involves improving ways to use available antibiotics on the market. Dr. Miller said that there are eight National Institutes of Health–funded trials aimed at this approach, including short-course therapy, narrow-spectrum therapies, combination vs. monotherapy, and pharmacodynamic dosing guidance.
Dr. Miller said that she had no relevant financial disclosures to make.